Report Detail

Pharma & Healthcare Global Consumer Acne Medicine Market Growth 2022-2028

  • RnM4475174
  • |
  • 02 August, 2022
  • |
  • Global
  • |
  • 105 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Consumer Acne Medicine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Consumer Acne Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Consumer Acne Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Consumer Acne Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Consumer Acne Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Consumer Acne Medicine players cover Galderma, Bausch Health, Teva, GlaxoSmithKline and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Consumer Acne Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Consumer Acne Medicine market, with both quantitative and qualitative data, to help readers understand how the Consumer Acne Medicine market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the Consumer Acne Medicine market and forecasts the market size by Type (OTC and Prescription Medicine,), by Application (Hospitals, Clinics and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
OTC
Prescription Medicine

Segmentation by application
Hospitals
Clinics
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
HUAPONT
Sine Pharma
Almirall SA
Johnson and Johnson
Pfizer
Lion Corporation

Chapter Introduction
Chapter 1: Scope of Consumer Acne Medicine, Research Methodology, etc.
Chapter 2: Executive Summary, global Consumer Acne Medicine market size (sales and revenue) and CAGR, Consumer Acne Medicine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Consumer Acne Medicine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Consumer Acne Medicine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Consumer Acne Medicine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma and HUAPONT, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Consumer Acne Medicine Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Consumer Acne Medicine by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Consumer Acne Medicine by Country/Region, 2017, 2022 & 2028
  • 2.2 Consumer Acne Medicine Segment by Type
    • 2.2.1 OTC
    • 2.2.2 Prescription Medicine
  • 2.3 Consumer Acne Medicine Sales by Type
    • 2.3.1 Global Consumer Acne Medicine Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Consumer Acne Medicine Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Consumer Acne Medicine Sale Price by Type (2017-2022)
  • 2.4 Consumer Acne Medicine Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Clinics
    • 2.4.3 Others
  • 2.5 Consumer Acne Medicine Sales by Application
    • 2.5.1 Global Consumer Acne Medicine Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Consumer Acne Medicine Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Consumer Acne Medicine Sale Price by Application (2017-2022)

3 Global Consumer Acne Medicine by Company

  • 3.1 Global Consumer Acne Medicine Breakdown Data by Company
    • 3.1.1 Global Consumer Acne Medicine Annual Sales by Company (2020-2022)
    • 3.1.2 Global Consumer Acne Medicine Sales Market Share by Company (2020-2022)
  • 3.2 Global Consumer Acne Medicine Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Consumer Acne Medicine Revenue by Company (2020-2022)
    • 3.2.2 Global Consumer Acne Medicine Revenue Market Share by Company (2020-2022)
  • 3.3 Global Consumer Acne Medicine Sale Price by Company
  • 3.4 Key Manufacturers Consumer Acne Medicine Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Consumer Acne Medicine Product Location Distribution
    • 3.4.2 Players Consumer Acne Medicine Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Consumer Acne Medicine by Geographic Region

  • 4.1 World Historic Consumer Acne Medicine Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Consumer Acne Medicine Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Consumer Acne Medicine Annual Revenue by Geographic Region
  • 4.2 World Historic Consumer Acne Medicine Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Consumer Acne Medicine Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Consumer Acne Medicine Annual Revenue by Country/Region
  • 4.3 Americas Consumer Acne Medicine Sales Growth
  • 4.4 APAC Consumer Acne Medicine Sales Growth
  • 4.5 Europe Consumer Acne Medicine Sales Growth
  • 4.6 Middle East & Africa Consumer Acne Medicine Sales Growth

5 Americas

  • 5.1 Americas Consumer Acne Medicine Sales by Country
    • 5.1.1 Americas Consumer Acne Medicine Sales by Country (2017-2022)
    • 5.1.2 Americas Consumer Acne Medicine Revenue by Country (2017-2022)
  • 5.2 Americas Consumer Acne Medicine Sales by Type
  • 5.3 Americas Consumer Acne Medicine Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Consumer Acne Medicine Sales by Region
    • 6.1.1 APAC Consumer Acne Medicine Sales by Region (2017-2022)
    • 6.1.2 APAC Consumer Acne Medicine Revenue by Region (2017-2022)
  • 6.2 APAC Consumer Acne Medicine Sales by Type
  • 6.3 APAC Consumer Acne Medicine Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Consumer Acne Medicine by Country
    • 7.1.1 Europe Consumer Acne Medicine Sales by Country (2017-2022)
    • 7.1.2 Europe Consumer Acne Medicine Revenue by Country (2017-2022)
  • 7.2 Europe Consumer Acne Medicine Sales by Type
  • 7.3 Europe Consumer Acne Medicine Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Consumer Acne Medicine by Country
    • 8.1.1 Middle East & Africa Consumer Acne Medicine Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Consumer Acne Medicine Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Consumer Acne Medicine Sales by Type
  • 8.3 Middle East & Africa Consumer Acne Medicine Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Consumer Acne Medicine
  • 10.3 Manufacturing Process Analysis of Consumer Acne Medicine
  • 10.4 Industry Chain Structure of Consumer Acne Medicine

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Consumer Acne Medicine Distributors
  • 11.3 Consumer Acne Medicine Customer

12 World Forecast Review for Consumer Acne Medicine by Geographic Region

  • 12.1 Global Consumer Acne Medicine Market Size Forecast by Region
    • 12.1.1 Global Consumer Acne Medicine Forecast by Region (2023-2028)
    • 12.1.2 Global Consumer Acne Medicine Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Consumer Acne Medicine Forecast by Type
  • 12.7 Global Consumer Acne Medicine Forecast by Application

13 Key Players Analysis

  • 13.1 Galderma
    • 13.1.1 Galderma Company Information
    • 13.1.2 Galderma Consumer Acne Medicine Product Offered
    • 13.1.3 Galderma Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Galderma Main Business Overview
    • 13.1.5 Galderma Latest Developments
  • 13.2 Bausch Health
    • 13.2.1 Bausch Health Company Information
    • 13.2.2 Bausch Health Consumer Acne Medicine Product Offered
    • 13.2.3 Bausch Health Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Bausch Health Main Business Overview
    • 13.2.5 Bausch Health Latest Developments
  • 13.3 Teva
    • 13.3.1 Teva Company Information
    • 13.3.2 Teva Consumer Acne Medicine Product Offered
    • 13.3.3 Teva Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Teva Main Business Overview
    • 13.3.5 Teva Latest Developments
  • 13.4 GlaxoSmithKline
    • 13.4.1 GlaxoSmithKline Company Information
    • 13.4.2 GlaxoSmithKline Consumer Acne Medicine Product Offered
    • 13.4.3 GlaxoSmithKline Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 GlaxoSmithKline Main Business Overview
    • 13.4.5 GlaxoSmithKline Latest Developments
  • 13.5 Mylan
    • 13.5.1 Mylan Company Information
    • 13.5.2 Mylan Consumer Acne Medicine Product Offered
    • 13.5.3 Mylan Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 Mylan Main Business Overview
    • 13.5.5 Mylan Latest Developments
  • 13.6 Almirall
    • 13.6.1 Almirall Company Information
    • 13.6.2 Almirall Consumer Acne Medicine Product Offered
    • 13.6.3 Almirall Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Almirall Main Business Overview
    • 13.6.5 Almirall Latest Developments
  • 13.7 Sun Pharma
    • 13.7.1 Sun Pharma Company Information
    • 13.7.2 Sun Pharma Consumer Acne Medicine Product Offered
    • 13.7.3 Sun Pharma Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Sun Pharma Main Business Overview
    • 13.7.5 Sun Pharma Latest Developments
  • 13.8 Mayne Pharma
    • 13.8.1 Mayne Pharma Company Information
    • 13.8.2 Mayne Pharma Consumer Acne Medicine Product Offered
    • 13.8.3 Mayne Pharma Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Mayne Pharma Main Business Overview
    • 13.8.5 Mayne Pharma Latest Developments
  • 13.9 HUAPONT
    • 13.9.1 HUAPONT Company Information
    • 13.9.2 HUAPONT Consumer Acne Medicine Product Offered
    • 13.9.3 HUAPONT Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 HUAPONT Main Business Overview
    • 13.9.5 HUAPONT Latest Developments
  • 13.10 Sine Pharma
    • 13.10.1 Sine Pharma Company Information
    • 13.10.2 Sine Pharma Consumer Acne Medicine Product Offered
    • 13.10.3 Sine Pharma Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Sine Pharma Main Business Overview
    • 13.10.5 Sine Pharma Latest Developments
  • 13.11 Almirall SA
    • 13.11.1 Almirall SA Company Information
    • 13.11.2 Almirall SA Consumer Acne Medicine Product Offered
    • 13.11.3 Almirall SA Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Almirall SA Main Business Overview
    • 13.11.5 Almirall SA Latest Developments
  • 13.12 Johnson and Johnson
    • 13.12.1 Johnson and Johnson Company Information
    • 13.12.2 Johnson and Johnson Consumer Acne Medicine Product Offered
    • 13.12.3 Johnson and Johnson Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Johnson and Johnson Main Business Overview
    • 13.12.5 Johnson and Johnson Latest Developments
  • 13.13 Pfizer
    • 13.13.1 Pfizer Company Information
    • 13.13.2 Pfizer Consumer Acne Medicine Product Offered
    • 13.13.3 Pfizer Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Pfizer Main Business Overview
    • 13.13.5 Pfizer Latest Developments
  • 13.14 Lion Corporation
    • 13.14.1 Lion Corporation Company Information
    • 13.14.2 Lion Corporation Consumer Acne Medicine Product Offered
    • 13.14.3 Lion Corporation Consumer Acne Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Lion Corporation Main Business Overview
    • 13.14.5 Lion Corporation Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Consumer Acne Medicine. Industry analysis & Market Report on Consumer Acne Medicine is a syndicated market report, published as Global Consumer Acne Medicine Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Consumer Acne Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,942.64
5,885.28
3,444.06
6,888.12
565,909.20
1,131,818.40
306,122.40
612,244.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report